Preliminary Clinical Data From Ongoing Phase 2 Study With Enhancer of Zeste Homolog 2 (EZH2) Inhibitor CPI-0209 in Patients With Advanced Solid Tumors or Hematologic Malignancies

  1. Kindler, H.
  2. Harvey, R.D.
  3. Duska, L.R.
  4. Gandhi, L.
  5. Sullivan, R.J.
  6. Gastinne, T.
  7. Kwiatek, M.
  8. García-Sancho, A.M.
  9. Hadar, N.
  10. Kann, L.
  11. Faulhaber, N.
  12. Drescher, C.
Revista:
European Journal of Cancer

ISSN: 1879-0852,  0959-8049

Any de publicació: 2022

Volum: 174

Pàgines: S31-S32

Tipus: Article

DOI: 10.1016/S0959-8049(22)00884-X GOOGLE SCHOLAR lock_openAccés obert editor

Objectius de Desenvolupament Sostenible